Paxlovid reduces risk of Long COVID
Veterans Health Administration sent this bulletin at 11/07/2022 10:00 AM EST|
no topic |
Department of
|
||
 |
no topic |
|
11/06/2022 11:24 PM EST
Today, VA released a study showing the medication Paxlovid can reduce the risk of symptoms of 'Long COVID,' which affects millions of people in the U.S. and around the world. In the interest of public health, the study, 'Nirmatrelvir and the risk of post-acute sequelae of COVID-19,' was released before peer-review on the pre-print server medRxiv.
|
Keep updated & let us know how we're doing. |
 |
 |
 |
 |
 |
 |
|
You have received this message because you are subscribed to Veterans Health. Access your Subscriber Preferences to make changes to your subscription or Unsubscribe. Get this as a forward? Sign Up to receive updates from Veterans Health. Having questions or problems? Please visit subscriberhelp.govdelivery.com for assistance. |
||
 |